Cefpirome
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-{[(6R,7R)-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-5H,6H,7H-cyclopenta[b]pyridin-1-ium | |
| Identifiers | |
| CAS number | 84957-29-9 |
| ATC code | J01DE02 |
| PubChem | CID 6917674 |
| KEGG | D07649 |
| Chemical data | |
| Formula | C22H22N6O5S2 |
| Mol. mass | 514.58 g/mol |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | ? |
Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria. It is marketed under the brand name of CEFROM by sanofi aventis group india .
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |

